What to Know About New Prostate Cancer Screening Recommendations
Community vote
No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.
Tried-it reports
Lived experience sits next to the community vote. Official sources never override either.
Universal screening for the disease has long been a subject of controversy. Imported from RSS. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - PubMed: The Role of Nuclear Medicine in Prostate Cancer — https://pubmed.ncbi.nlm.nih.gov/41300900/ - PubMed: Personalized risk-adapted models in prostate cancer during active surveillance using MRI-a narrative review — https://pubmed.ncbi.nlm.nih.gov/40185922/ - ClinicalTrials.gov: A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) — https://clinicaltrials.gov/study/NCT06052306
Not medical advice. We don't sell peptides. Votes and comments are community opinion, not clinical guidance.
Comments
No comments yet. Got receipts? Drop them.